Lease for Business Premises between GED Grundstücksentwicklungs-Gesellschaft mbH, Henkelstr. 164 40589 Düsseldorf (Turnover Tax No.) 106/5709/2142 - Lessor/GED - and Coley Pharmaceutical GmbH Represented by Dr. Christian Schetter, Managing Director...Lease Agreement • March 9th, 2007 • Coley Pharmaceutical Group, Inc. • Pharmaceutical preparations
Contract Type FiledMarch 9th, 2007 Company IndustryThe Life Science Center Düsseldorf, consisting of a technology and founders centre and an office building, pursues the objective of offering young enterprises, established companies, scientific institutions and groups of researchers working in life sciences (*) and their associated technologies (**), also including service companies and institutions, an optimum platform for their further development. The investor, Gründstückgesellschaft Düsseldorf mbH (GED), rents out office and laboratory space in the technology and founders centre to the above mentioned technology-oriented and research and development-intensive user groups and in this way would like to contribute to the future orientation of the economic area of Düsseldorf and to the maintenance and creation of jobs in the high technology sector. The cooperation of the lessees of the technology and founders centre and of the office building with scientific establishments, primarily the Heinrich Heine University in Düsseldorf, also am
Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Company’s application requesting confidential treatment under Rule 24b-2 of the Exchange Act. Amendment #2 To Infectious Diseases...Infectious Diseases License Agreement • March 9th, 2007 • Coley Pharmaceutical Group, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledMarch 9th, 2007 Company Industry JurisdictionThis Amendment #2 to the Strategic Alliance: License Agreement Infectious Diseases dated December 18, 1998 is made as of July 19, 2006 (the “Effective Date”), by and between COLEY PHARMACEUTICAL GROUP, INC., a Delaware corporation having a place of business at Wellesley Gateway, 93 Worcester Street, Suite 101, Wellesley, Massachusetts 02481 (“Coley”), and GLAXO GROUP LIMITED a British corporation having a place of business at 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom (hereinafter referred to as “GSK) (each individually a “Party” and collectively the “Parties”).